The Second Affiliated Hospital of Air Force Medical University
Xi'an, Shaanxi, 710038, China
NCT Number: NCT06944834
The objective of this study is to evaluate the safety and efficacy of minimally invasive, wireless brain-machine interface system (WRS) in patients with paralysis (resulting from spinal cord injuries, brainstem strokes, amyotrophic lateral sclerosis, or other motor neuron diseases causing complete or incomplete quadriplegia) or bilateral upper limb amputations. By leveraging brain-machine interface alternative technology, participants can use brain signals to control external devices (such as moving cursors, wheelchairs, robotic arms, WeChat Mini Programs, and other physical assistive devices), thereby improving their motor function and quality of life.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Xi'an, Shaanxi, 710038, China
The objective of this study is to evaluate the safety and efficacy of minimally invasive, wireless brain-machine interface system (WRS) in patients with paralysis (resulting from spinal cord injuries, brainstem strokes, amyotrophic lateral sclerosis, or other motor neuron diseases causing complete or incomplete quadriplegia) or bilateral upper limb amputations. By leveraging brain-machine interface alternative technology, participants can use brain signals to control external devices (such as moving cursors, wheelchairs, robotic arms, WeChat Mini Programs, and other physical assistive devices), thereby improving their motor function and quality of life.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation of the device and follow-up
Time frame: Within 6 months after implantation
The incidence of adverse events associated with the device or surgical procedure
Time frame: 6 months after the implantation
Validation of motor function improvement through cursor control performance metrics: the accuracy of of task list (number of correct items/ number of all items), the higher the better.
Time frame: 6 months after the implantation
Validation of motor function improvement is demonstrated through cursor control performance metrics, particularly path efficiency (the ratio of optimal to actual movement path). Higher values indicate better motor control performance.
Time frame: 6 months after the implantation
Motor function improvement is validated through cursor control performance metrics, particularly time consumption (total task completion duration). Shorter durations indicate superior motor performance.
Time frame: 3, 15, 30, 90, 180 days after implantation
The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) scale was used to evaluate overall neurological status. The higher the scale score, the better the overall neurological status.
Time frame: 3, 15, 30, 90, 180 days after implantation
Variations in the MOS item short from health survey (SF-36) scores were evaluated during both the main study period and long-term follow-up phase (comparing baseline to 6-month post-implantation assessments). The score values directly reflect health status - higher scores indicate better functional outcomes and superior quality of life.
Time frame: 3, 15, 30, 90, 180 days after implantation
Variations in Montreal Cognitive Assessment (MoCA) scores scores were evaluated during both the main study period and long-term follow-up phase (comparing baseline to 6-month post-implantation assessments). Elevated scores are associated with improved cognitive function.
Time frame: 3, 15, 30, 90, 180 days after implantation
Variations in Patient Health Questionnaire (PHQ-9) scores were evaluated during both the main study period and long-term follow-up phase (comparing baseline to 6-month post-implantation assessments). Higher scores indicate poorer psychological status.
Time frame: 3, 15, 30, 90, 180 days after implantation
Variations in Hamilton Anxiety Rating Scale (HAMA) scores were evaluated during both the main study period and long-term follow-up phase (comparing baseline to 6-month post-implantation assessments). Higher scores indicate poorer psychological status.
Time frame: 3, 15, 30, 90, 180 days after implantation
Variations in Hamilton Depression Rating Scale (HAMD) scores were evaluated during both the main study period and long-term follow-up phase (comparing baseline to 6-month post-implantation assessments). Higher scores indicate poorer psychological status.
Contact information is provided by the study sponsor or research team.
Shanghai StairMed Technology Co., Ltd.
Industry
Acronym: STAIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07127172
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
London, Greater London, United Kingdom
View Trial DetailsNCT06992596
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Abu Dhabi, United Arab Emirates
View Trial DetailsNCT05321017
Central Nervous System Diseases, Nervous System Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT07640711
Central Nervous System Diseases, Nervous System Diseases
Utrecht, Netherlands
View Trial Details